Cargando…

A meta‐analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases

BACKGROUND: Some previous studies explored associations between vascular endothelial growth factor receptor 2 (VEGFR2) polymorphisms and atherosclerotic cardiovascular diseases (ASCVD), with conflicting findings. HYPOTHESIS: We thought that VEGFR2 polymorphisms may influence susceptibility to ASCVD....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Ge, Hui, Peng, Longyun, Wang, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788482/ https://www.ncbi.nlm.nih.gov/pubmed/31339592 http://dx.doi.org/10.1002/clc.23233

Ejemplares similares

Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study
por: Chen, Guanmin, et al.
Publicado: (2021)

Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
por: Ding, Xiaobo, et al.
Publicado: (2021)

Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease
por: Fonarow, Gregg C., et al.
Publicado: (2021)

Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry
por: Lowenstern, Angela, et al.
Publicado: (2021)

Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases
por: Deo, Salil V., et al.
Publicado: (2023)

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients
por: Marchini, J.F.M., et al.
Publicado: (2017)

Relationship between calculated total antioxidant status and atherosclerotic coronary artery disease
por: Anvari, Maryam Sotoudeh, et al.
Publicado: (2016)

Analysis of atherosclerotic plaque distribution in the carotid artery
por: Yang, Shin‐Seok, et al.
Publicado: (2022)

The Association between VEGFR Gene Polymorphisms and Stroke: A Meta-Analysis
por: Qiu, Shi, et al.
Publicado: (2016)

Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
por: Hatipsoylu, Erdinç, et al.
Publicado: (2019)

Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis
por: Wu, Mingxing, et al.
Publicado: (2017)

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System
por: Vassy, Jason L., et al.
Publicado: (2020)

Genetic association between plasminogen activator inhibitor‐1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta‐analysis
por: Huang, Guangbin, et al.
Publicado: (2019)

Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from Getting to an imprOved Understanding of Low‐Density lipoprotein cholesterol and dyslipidemia management (GOULD)
por: Shaik, Aleesha, et al.
Publicado: (2022)

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
por: Şalk, Sultan, et al.
Publicado: (2022)

Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study
por: Levin, Michael G., et al.
Publicado: (2021)

Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease
por: Poreba, Malgorzata, et al.
Publicado: (2018)

Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2019)

Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2018)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Fetterman, Jessica L., et al.
Publicado: (2016)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Mediating effect of depression on the association between cardiovascular disease and the risk of all‐cause mortality: NHANES in 2005−2018
por: Ma, Xinxin, et al.
Publicado: (2023)

Role of chemokines in promoting instability of coronary atherosclerotic plaques and the underlying molecular mechanism
por: Zhong, Z.X., et al.
Publicado: (2014)

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus
por: Ren, Honghong, et al.
Publicado: (2021)

Comparison of coronary atherosclerotic disease burden between ST‐elevation myocardial infarction and non‐ST‐elevation myocardial infarction: Non‐culprit Gensini score and non‐culprit SYNTAX score
por: Tanaka, Takamasa, et al.
Publicado: (2020)

Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study
por: Deng, Fuxue, et al.
Publicado: (2021)

Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
por: Khera, Rohan, et al.
Publicado: (2020)

Growth differentiation factor‐15 and the risk of cardiovascular diseases and all‐cause mortality: A meta‐analysis of prospective studies
por: Xie, Shanhui, et al.
Publicado: (2019)

Associations between CD36 gene polymorphisms and susceptibility to coronary artery heart disease
por: Zhang, Y., et al.
Publicado: (2014)

Pericardial fat volume and coronary atherosclerotic markers among body mass index groups
por: Hassan, Mohammed Bader, et al.
Publicado: (2020)

Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES‐based cohort study
por: Ma, Ruicong, et al.
Publicado: (2022)

Measures of Financial Hardship From Health Care Expenses Among Families With a Member With Atherosclerotic Cardiovascular Disease in the US
por: Wang, Stephen Y., et al.
Publicado: (2022)

Carotid Atherosclerosis, Microalbuminuria, and Estimated 10-Year Atherosclerotic Cardiovascular Disease Risk in Sub-Saharan Africa
por: Nonterah, Engelbert A., et al.
Publicado: (2022)

Association Between Self-rated Health, Coronary Artery Calcium Scores, and Atherosclerotic Cardiovascular Disease Risk: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Orimoloye, Olusola A., et al.
Publicado: (2019)

Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis
por: Song, De-Hua, et al.
Publicado: (2016)

Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta‐analysis of adjusted observational studies
por: Vrsalovic, Mislav, et al.
Publicado: (2022)

Associations between Circulating VEGFR2(hi)-Neutrophils and Carotid Plaque Burden in Patients Aged 40-64 without Established Atherosclerotic Cardiovascular Disease
por: Genkel, Vadim, et al.
Publicado: (2022)

Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agqk3j8ut6ehufpiv2pghiovc4